We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 36

NASDAQ Biotechnology Index surpasses all-time high in 1Q13

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe

Life Tech shareholder sues to stop $13.6 billion sale to Thermo Fisher

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

According to a news source, Life Technologies shareholder Chang Choi has filed a lawsuit on behalf of a class of company shareholders alleging breach

Cincinnati investor closes $4.4 million fund to invest in startups

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 30 2011

Cincinnati-based CincyTech, a venture development company that invests in startup biotech, information technology and advanced manufacturing businesses, has announced the closing of a $4.4 million Fund II targeted for 10 to 12 new startups in southwest Ohio

Biotech investments rise in Q4 2012, but remain off for the year

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 24 2013

Pricewatershouse Coopers LLP has released its fourth quarter (Q4) and final 2012 venture capital investment reports and notes that "Biotechnology

Court dismisses fraud claims against investors who sued biotech startup

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 7 2011

A federal court in California has granted in part the motion that two biotech startup investors filed under the state's anti-SLAPP (strategic lawsuit against public participation) law to dismiss the company's counterclaims against them

New program to provide accelerated “speed-to-market” for medical device entrepreneurs

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 1 2012

The nonprofit Memphis Bioworks Foundation and Innova, a pre-seed, seed and early-stage investor, have announced a program designed to help entrepreneurs bring medical device products and companies to market

Court upholds drug profit sharing; pharma co. breached agreement to negotiate deal

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 7 2012

A Delaware court has issued a letter opinion finalizing its 2011 ruling requiring SIGA Technologies Inc. to share profits from its smallpox drug with PharmAthene, Inc. PharmAthene, Inc. v. SIGA Techs, Inc., No. 267-VCP (Del. Ch., decided May 31, 2012

North Carolina life sciences companies attract more than $1.1 billion in investments, grants

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 19 2011

After conducting its yearly survey of media reports, a North Carolina trade association has announced that life sciences companies brought in more than $1.1 billion in investments and grants to the state in the 12 months ending April 25, 2011, representing a 25 percent increase over the 12-month period ending April 2010

Barbados launches biotech initiative designed to shorten R&D process

  • Shook Hardy & Bacon LLP
  • -
  • Barbados
  • -
  • December 16 2010

The Barbados government has recently launched two initiatives to attract biotech companies to the island nation

Venture investing decreased in California in 2010, but executives bullish about biotech future

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 7 2011

With biotechnology employing some 268,000 people in California, industryexecutives reportedly remain optimistic about its future in the state despitea recent report indicating that biotech venture investments decreased in 2010